Alon Lazarus, Ph.D.

Arkin Bio Ventures

Dr. Alon Lazarus joined Arkin Holdings’ pharma division in 2013. He serves on the board of several of Arkin’s pharmaceutical companies, including Keros Therapeutics, and Lutris Pharma.

Prior to joining Arkin, Dr. Lazarus worked for the healthcare business development department of Yissum, the R&D arm of the Hebrew University of Jerusalem.

Dr. Lazarus holds a Ph.D in molecular biology and an MBA, both from the Hebrew University of Jerusalem.